(Q51705669)

10 April 2018

title

Dornase alfa in early cystic fibrosis lung disease. (English)

1 reference

10 April 2018

0 references

Philip J Robinson

1

1 reference

10 April 2018

publication date

1 September 2002

1 reference

10 April 2018

published in

Pediatric Pulmonology

1 reference

10 April 2018

volume

34

1 reference

10 April 2018

issue

3

1 reference

10 April 2018

page(s)

237-241

1 reference

10 April 2018

Detecting early structural lung damage in cystic fibrosis.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Early infection and progression of cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Evidence-based medicine in cystic fibrosis: how should practice change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Pus, deoxyribonucleic acid, and sputum viscosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Lower airway inflammation in infants and young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

Predictive 5-year survivorship model of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10136

21 January 2018

Identifiers

DOI

10.1002/PPUL.10136

1 reference

10 April 2018

1 reference

10 April 2018